Purpose.
This Funding Opportunity Announcement (FOA) issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), solicits grant applications proposing exceptionally innovative, high risk, original and/or unconventional exploratory research projects focused on the inception
credit:
and early stage development of highly innovative cancer-relevant technologies.
The emphasis of this FOA is on the development of technically innovative molecular and cellular analysis tools with the potential to (i) create new or challenge existing scientific and technological paradigms and/or (ii) overcome technological barriers in important areas of cancer research.
Projects must clearly demonstrate potential to produce a major impact in a broad area of biomedical or cancer-relevant research.
This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program.
Several IMAT FOAs of identical or closely related scientific scope using various funding mechanisms are available.
To facilitate selection, a separate Notice in the NIH Guide for Grants and Contracts provides brief cross-comparison and links to all the IMAT FOAs.
See NOT-CA-09-00 7.